Thyrocare to acquire diagnostic and pathological services of Vimta Lab 0 30.08.2024 09:47 Business Standard Vimta Labs through its diagnostic and pathological services business has recorded a revenue of Rs 30 crore during FY 2024 and Rs 7 crore in Q1 FY 2025. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
